Resultados da pesquisa - Boland, M.R.
- A mostrar 1 - 8 resultados de 8
-
1
-
2
Does Mode of Surgical Intervention Based on Oncotype DX Score Influence Disease Recurrence in Early Breast Cancer? Por Aherne, T. M., Boland, M. R., Catargiu, D., Bashar, K., McVeigh, T. P., Brodie, C., Sweeney, K. J.
Publicado em 2020Text -
3
Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis Por Davey, M.G., Ryan, É.J., Boland, M.R., Barry, M.K., Lowery, A.J., Kerin, M.J.
Publicado em 2021Text -
4
-
5
Incidental Phaeochromocytoma on Staging PET-CT in a Patient with a Sigmoid Tumour and Situs Inversalis Totalis Por Boland, M. R., Lowery, A. J., Walsh, S., Beddy, D., Prichard, R. S., O'Shea, D., Skehan, S. J., McDermott, E. W.
Publicado em 2014Text -
6
Is radiomic MRI a feasible alternative to OncotypeDX(®) recurrence score testing? A systematic review and meta-analysis Por Davey, M G, Davey, M S, Ryan, É J, Boland, M R, McAnena, P F, Lowery, A J, Kerin, M J
Publicado em 2021Text -
7
Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy Por Boland, M. R., McVeigh, T. P., O'Flaherty, N., Gullo, G., Keane, M., Quinn, C. M., McDermott, E. W., Lowery, A. J., Kerin, M. J., Prichard, R. S.
Publicado em 2017Text -
8
The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer Por Davey, M G, Ryan, É J, Folan, P J, O’Halloran, N, Boland, M R, Barry, M K, Sweeney, K J, Malone, C M, McLaughlin, R J, Kerin, M J, Lowery, A J
Publicado em 2021Text